Buscar
Mostrando ítems 1-10 de 24
Pharmacological and Psychosocial Management of Mental, Neurological and Substance Use Disorders in Low- and Middle-Income Countries: Issues and Current Strategies
(Adis Int Ltd, 2013-09-01)
Mental, neurological, and substance use disorders (MNS) are among the largest sources of medical disability in the world, surpassing both cardiovascular disease and cancer. the picture is not different in low- and middle-income ...
Risk factors across the life course and dementia in a Brazilian population: results from the Sao Paulo Ageing & Health Study (SPAH)
(OXFORD UNIV PRESS, 2008)
Background Several mechanisms have been suggested to explain the association between adversities across life and dementia. This study aimed to investigate the association between indicators of socioeconomic disadvantages ...
The 5/95 gap in the indexation of psychiatric journals of low- and middle-income countries
(Wiley-Blackwell, 2010-02-01)
Objective:To investigate the relationship between science production and the indexation level of low- and middle-income countries (LAMIC) journals in international databases.Method:Indicators of productivity in research ...
Pharmacological treatment of schizophrenia
(Informa Healthcare, 2012-01-01)
Background: A lack of human and financial resources, as well as effective health systems, leads to a worldwide treatment gap for schizophrenia. the aim of this paper is to propose evidence-based antipsychotics interventions ...
Scarcity and inequity of mental health research resources in low-and-middle income countries: A global survey
(Elsevier B.V., 2010-03-01)
Objective: To map mental health research capacity and resources in low-and-middle-income countries (LAMIC) for the years 1993-2003.Method: Mental health researchers from 114 LAMIC in three continents were identified through ...